COVID-19 vaccines
AstraZeneca has secured crucial approval for a revolutionary new medicine that will greatly improve the lives of Scots cancer patients with the most common form of leukaemia. The Scottish Medicines Consortium has greenlit acalabrutinib, an oral pill that can be taken at home, which targets the disease while minimizing debilitating
COVID-19 vaccines
The Jupiter Global Sustainable Equities Fund, managed by Abbie Llewellyn-Waters, has excelled in the healthcare sector during the past year. The fund's focus on preventative healthcare and economically sustainable companies has led it to invest in top-performing brands such as CSL and Danaher. These companies have played a
COVID-19 vaccines
The Serum Institute of India (SII), the maker of Covishield, has joined the ranks of foreign vaccine companies like Pfizer and Moderna in seeking indemnity for vaccine failures or side effects. This follows the government's hint at granting indemnity to Pfizer and Moderna, a condition put forth by
COVID-19 vaccines
Indian Foreign Secretary Harsh V Shringla has revealed that the country is engaging in discussions with major pharmaceutical companies, including Pfizer, Johnson & Johnson, and Moderna, to secure and possibly manufacture COVID-19 vaccines locally. This initiative comes as India aims to boost vaccine production for both domestic consumption and export.
COVID-19 vaccines
A recent report from AstraZeneca has raised concerns about the mortality rate associated with the Pfizer coronavirus vaccine in six European countries. According to the 12-page report, titled "Restoring Confidence in COVID-19 Vaccines and Improved Co-operation Between Regulatory, Healthcare Agencies and Pharmaceutical Companies -- A Call for Action,"
COVID-19 vaccines
A recent survey conducted by Social Weather Stations (SWS) has shown that six out of ten Filipinos prefer vaccines made in the United States, with 63% of respondents expressing a desire to receive US-made vaccine shots. The survey, which involved 1,200 respondents, also highlighted the top five preferred countries
COVID-19 vaccines
The study published in a pre-print version on medRxiv* provides evidence on the effectiveness of the Pfizer-BioNTech and AstraZeneca vaccines at preventing mortality among older individuals with coronavirus disease 2019 (COVID-19). The analysis of over 48,000 individuals aged 70 years and older found that vaccinated individuals had a reduced
COVID-19 vaccines
The United States will send tens of millions of doses of AstraZeneca's vaccine abroad, despite the fact that its regulatory system has not yet approved the vaccine for use in the country. This move has been met with pressure from the international community, with many countries urging the
COVID-19 vaccines
The United States has pre-ordered hundreds of millions of COVID-19 vaccine doses, with the government paying billions to pharmaceutical companies like Pfizer and Moderna. This approach has eliminated barriers to access for millions of people, including those who are uninsured or undocumented. However, once the federal health emergency ends, the
COVID-19 vaccines
As the global COVID-19 vaccine shortage persists, US President Joe Biden has joined the call of 100 nations to waive vaccine producer patents to speed up vaccination efforts. However, the problem is more complex than presented, with multiple patents involved in vaccine production and a lack of sufficient production facilities.
COVID-19 vaccines
The US Food and Drug Administration is set to approve Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 next week, based on a report stating that the FDA is reviewing scientific data provided by Pfizer. This comes as another American pharma firm, Moderna, is also testing
COVID-19 vaccines
The head of India's Serum Institute, the world's biggest vaccine manufacturer, has warned that the country's severe vaccine shortage will continue until July, when production is expected to rise from about 60m-70m doses a month to 100m. The shortage has been exacerbated by the
